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Purpose: Eye and hand motor dysfunction may be present early in the disease course of relapsing-re-
mitting multiple sclerosis (RRMS), and can affect the results on visual and written cognitive tests. We
aimed to test for differences in saccadic initiation time (SI time) between RRMS patients and healthy
controls, and whether SI time and hand motor speed interacted with the written version of the Symbol
Digit Modalities Test (wSDMT).
Methods: Patients with RRMS (N¼44, age 35.177.3 years), time since diagnosis o3 years and matched
controls (N¼41, age 33.276.8 years) were examined with ophthalmological, neurological and neu-
ropsychological tests, as well as structural MRI (white matter lesion load (WMLL) and brainstem lesions),
visual evoked potentials (VEP) and eye-tracker examinations of saccades.
Results: SI time was longer in RRMS than controls (po0.05). SI time was not related to the Paced Au-
ditory Serial Addition Test (PASAT), WMLL or to the presence of brainstem lesions. 9 hole peg test (9HP)
correlated signiﬁcantly with WMLL (r¼0.58, po0.01). Both SI time and 9HP correlated negatively with
the results of wSDMT (r¼0.32, po0.05, r¼0.47, po0.01), but none correlated with the results of
PASAT.
Conclusions: RRMS patients have an increased SI time compared to controls. Cognitive tests results,
exempliﬁed by the wSDMT, may be confounded by eye and hand motor function.
& 2015 The Authors. Published by Elsevier B.V. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Multiple sclerosis (MS) is an inﬂammatory disease affecting the
central nervous system showing both local and more widespread
diffuse inﬂammation and neurodegeneration. Early features ofB.V. This is an open access article u
mology, Oslo University Hos-
ax: þ47 22119075.
. Nygaard),
ent),
in.uio.no (B. Laeng),
@ki.se (S. Damangir),
@ous-hf.no (L. Etholm),
edisin.uio.no (L. Drolsum),
ous-hf.no (E.G. Celius).relapsing-remitting multiple sclerosis (RRMS) are varied and may
include eye motor disturbances (Reulen et al., 1983; Frohman et al.,
2005; Graves and Balcer, 2010), ﬁne motor control of the hand
(Cutter et al., 1999) or cognitive dysfunction (Amato and Ponziani,
2001; Amato et al., 2010).
The Symbol Digit Modalities Test (SDMT) (Aron, 1982) is a
widely used test of processing speed, recently suggested as sen-
tinel test for cognitive impairment in multiple sclerosis (Van
Schependom et al., 2014). It is part of several test batteries used in
the assessment of cognitive impairment in MS patients (Benedict
et al., 2002; Langdon et al., 2011) and is suggested for use in
clinical trials (Benedict et al., 2012). Because of the wide use of the
SDMT (Benedict et al., 2004; Drake et al., 2010; Langdon et al.,
2011), it is important to identify possible input or output level
problems related to the procedure of the test.
Saccadic initiation time (SI time), i.e. the time from a centralnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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increased in patients with MS (Reulen et al., 1983) and hence
constitute an input problem when performing the SDMT. Complex
tests of eye movements, like tests of anti-saccades, have been as-
sociated with cognitive dysfunction in MS (Fielding et al., 2009a,
2012), and MS patients appear to spend excessive time on saccadic
tasks with distractor stimuli (Fielding et al., 2009b). Recently a test
for eye motor speed has been suggested as a bedside assessment
tool in MS, as the number of speeded saccades for 30 s was related
to both visual and non-visual cognitive tests (Roberg et al., 2014).
However, to our knowledge, SI time, relevant for an effective
completion of the SDMT, has not been studied in MS patients.
Motor function could affect the response to cognitive tests, like
the SDMT. The neuropsychological test batteries for MS patients,
like the MACFIMS and BICAMS, where SDMT is included, have
recommended the use of the oral version of the SDMT because of
possible motor interactions with the written version (Benedict
et al., 2002; Langdon et al., 2011). However, oral motor slowing has
been found to affect the results of the oral SDMT (oSDMT) (Arnett
et al., 2008), indicating that an oral response to the SDMT may not
be ideal. The emergence of new disease modifying treatments
requires clinicians to carefully monitor their patients' disease
progression early in the disease course. In particular the increasing
attention on cognitive dysfunction in MS warrants a need for quick
and easy assessment of cognitive function in early MS patients.
These patients may have a very low disability and minor motor
dysfunction. The written version of the SDMT, (wSDMT) is easier
to administer for the clinicians and probably would feel more
discreet to complete for the patients, and it would therefore be an
advantage to both parties if this version of the test could replace
the oral version in some instances. It is, however, not known
whether hand motor speed is associated with the test results on
the wSDMT in such patients.
In this study we aimed at testing whether decrements in eye
and hand motor control could confound the test score of the visual
SDMT with written response (wSDMT) in early MS patients.2. Materials and methods
2.1. Patients and controls
Relapsing-remitting MS (RRMS) patients diagnosed within the
last three years with no drug abuse and no other neurologic or
psychiatric disease, were investigated (n¼48). Healthy controls
(n¼47) were included for the ophthalmological and eye-tracker
analyses, but not tested neurologically. They were recruited from
the hospital and university environment and had no medical
conditions known to affect the visual pathways. They were mat-
ched on age and gender at a group level and, after exclusion (four
patients and ﬁve controls because of technical problems with the
eye tracker, one patient because of febrile acute illness and one
control because of possible demyelinating disease), 44 patients
and 41 controls were eligible for analyses (Table 1).
All participants gave written informed consent and the project
was approved by the regional committee for medical and health
research ethics (REK).
2.2. Clinical evaluation
All patients were tested by the same trained neurologist (GON)
with the Expanded Disability Status Score (EDSS) and the 9 Hole
Peg test (9HP) for hand motor speed. They also underwent a
thorough neuropsychological assessment (Nygaard et al., 2014).
Results of the auditory 3 s version of the Paced Auditory Serial
Addition Test (PASAT) (Gronwall, 1977) performed by the patients,and wSDMT (Aron, 1982) performed by all participants, are re-
ported. Ophthalmological examinations were performed by the
same trained ophthalmologist (SRB).
All patients underwent detailed MRI within a week of the other
examinations. White matter lesion load (WMLL) was estimated
from FLAIR and MPRAGE sequences, using the Cascade software,
previously applied to an overlapping MS sample (ki.se/en/nvs/
cascade) (Damangir et al., 2012; Nygaard et al., 2014). A subset of
the patients (n¼32) were examined by a trained neuroradiologist
(PS) and rated according to the presence of white matter lesions
(WML) of the brainstem.
Patients' visual evoked potential latency to P100 (VEP P100)
were obtained with dimmed light (25 lx) and the screen placed
100 cm in front of the eyes with checkerboard patterns (check size
65′, 2 Hz with a 16″ cathode ray tube screen). Three hundred re-
sponses were averaged from the mid-occipital lobe (MO, deﬁned
to be 5 cm above inion) referenced Fz, (deﬁned by the 10/20 sys-
tem) with 1–100 Hz band-pass ﬁlter. Rejection level was set to
7100 μV.
Saccades were acquired using an iView X Hi-Speed eye-track-
ing (SensoMotoric Instruments, Teltow, Germany). The partici-
pants were seated approximately 70 cm from the 18.5″ monitor,
measuring a diagonal length of 47 cm, and the constant display
resolution was set to 16801050 pixels. Binocular data were re-
corded at a sampling rate of 60 Hz. The eye-tracking system is
accurate to less than 0.4°.
Participants ﬁrst ﬁxated on a central cross and made saccadic
movements as fast as possible towards a star in the corner of the
screen cued by a central appearing arrow instantly replacing the
cross (Fig. 1a and b). The test's primary output was SI time, deﬁned
as the time from the appearance of the arrow until the onset of an
appropriate saccade.
Target areas of interest (tAOI) were deﬁned by circles sur-
rounding the stars in the four corners of the screen (Fig. 1c). Time
to tAOI (ttA) was calculated as the time from appearance of the
central arrow to the participants' saccade entered the tAOI.
Each participant was given eight trials. The ﬁrst trial was re-
garded as a test and discarded. Altogether, 286/308 (93%) of the
trials of the patients and 273/287 (95%) of the trials of the controls
had good quality and were included in the analyses.
2.3. Statistical analyses
SPSS version 22, Chicago, IL was used for statistical analyses.
Independent samples t-test and χ2-tests were used to test for
differences between patients and controls and Pearson bivariate
and partial correlations were used to test for associations between
the same groups. Linear regression analyses were used to assess
the association between motor function and cognitive tests. A
signiﬁcance level of 0.05 was applied for all analyses.3. Results
3.1. Clinical features
The background and clinical characteristics are listed in Table 1.
The groups were comparable concerning age, gender distribution,
visual acuity and test results on the wSDMT. The controls' educa-
tional level was on average two years higher than that of the pa-
tients. VEP p100 was in normal range on group level. Almost half
of the patients had undergone known or subclinical optic neuritis
(ON) of either or both eyes prior to the examinations.
The patients had a signiﬁcantly longer SI time than the controls
while ttA was comparable (Table 2).
Fig. 1. Screenshots from the eye tracker. (A) ﬁxation slide (corner stars¼saccadic
targets); (B) task (saccadic cue¼pointing arrow); (C) AOIs.
Table 1
Background.
Patients Controls Difference
N¼44 N¼41 95% CI p-
Value
Female, n (%) 32 (73) 30 (73) 1.000
Age, years7SD 35.177.3 33.276.8 1.2 to
4.9
0.225
Education, years7SD 15.272.1 16.97 3.0 2.9 to
0.6
0.003
Time since diagnosis,
months7SD
16.3711.2
Disease duration,
months7SD
30.7728.3
Disease modulatory treat-
ment, n (%)
36 (82)
EDSS, mean7SD 1.870.8
EDSS, median (min–max) 1.5 (0–3.5)
9HP, sec, mean7SDa 20.873.8
T25FWT, sec, mean7SDa 4.070.6
Visual acuity, left eye,
LogMar7SD
0.0470.12 0.0870.08 0.01 to
0.08
0.097
Visual acuity, right eye,
LogMar7SD
0.0870.09 0.0670.11 0.06 to
0.02
0.381
Previous optic neuritis
Left eye, n (%) 9 (21)
Right eye, n (%) 11 (25)
Both eyes, n (%) 1 (2)
White matter lesion load,
mm3, mean7SDa
5.473.6
Presence of lesions in
brainstem, n (%)
19/32 (59%)
VEP, delay to p100, left eye,
mean7SDb
107.079.0
VEP, delay to p100, right
eye, mean7SDb
106.977.1
wSDMT, correct answers,
mean7SDc
53.978.9 55.878.5 5.8 to
0.3
0.321
PASAT, correct answers,
mean7SDa
47.479.3
a n¼42 s.
b For two patients VEP delay was not quantiﬁable on the left or both eyes.
c n¼40 controls.
Table 2
Test results of saccades in patients and controls.
Patients Controls Difference
n¼44 n¼41 95% CI p-Value
Saccadic initiation time,
ms7SD
351.7769.4 326.0745.0 0.3–51.2 0.047
Time to target AOI, ms7SD 468.5784.6 446.0764.6 10.2 to
55.1
0.175
Number of valid saccades
per participant, total7SD
6.571.1 6.770.8 0.6 to
0.3
0.442
G.O. Nygaard et al. / Multiple Sclerosis and Related Disorders 4 (2015) 585–589 5873.2. Association between motor function, disease characteristics and
cognitive test results
The patients' SI time was associated with wSDMT, but not with
PASAT, as shown in Fig. 2a and b. Furthermore, there were no
associations between the patients' SI time and WMLL or VEP P100
(Table 3). ON patients did not present longer SI time than the other
patients (t¼1.559, p¼0.126), and the patients with and without
WML of the brain-stem had similar SI time (t¼0.182, p¼0.857).
Furthermore, there was no signiﬁcant association between SI time
and age (r¼0.232, p¼0.129).
As illustrated in Fig. 2c and d, the patients' hand function (9HP)
was associated with the wSDMT, but not with the PASAT. 9HP was
also associated with WMLL, but not with VEP P100 latency (Ta-
ble 3) or WML of the brain-stem (p¼1.000). Hand function was,
however, associated with age (r¼0.481, po0.001). The association
between hand function, wSDMT and WMLL, was still signiﬁcant
after correcting for age (9HP versus wSDMT (partial): rp¼0.349,
p¼0.025, 9HP versus WMLL (partial): rp¼0.576, po0.001).
As expected from previous studies (Brochet et al., 2008; Drake
et al., 2010) the results of the wSDMT and PASAT were associated
(r¼0.457, p¼0.002). When controlling for 9HP (r¼0.511,
p¼0.001), or SI time (r¼0.455, p¼0.003) this association was
unchanged.
In the healthy controls, we found no association neither be-
tween SI time and wSDMT (r¼0.189, p¼0.256), nor between
wSDMT and age (r¼0.227, p¼0.176).Univariate regression analysis showed 10% of the variance in
wSDMT could be explained by the results on SI time, and every
extra 10 ms of SI time was associated with a 0.41 point decrease in
the wSDMT (Fig. 2a). Regression analysis revealed that 22% of the
variance in wSDMT could be explained by the results on the 9HP,
and every extra second spent on the 9HP was associated with a
1.1 point decrease in wSDMT (Fig. 2c).
Multivariate linear regression with 9HP and SI time as in-
dependent variables and wSDMT as dependent variable revealed
that SI time did not add signiﬁcantly (p¼0.209) to the model
when controlling for 9HP.
Fig. 2. Association between motor function and cognitive tests in RRMS patients. The scatter plots illustrate the association between (a) SI time and wSDMT, (b) SI time and
PASAT, (c) 9HP and SDMT and (d) 9HP and PASAT, respectively. As illustrated, only wSDMT, and not PASAT, is associated with motor function in early RRMS patients.
Table 3
Correlations in RRMS patients.
WMLL VEP P100
r (p-value) r (p-Value)
SI time 0.038 (0.815) 0.104 (0.519)
9HP 0.579 (o0.001) 0.094 (0.560)
In the RRMS patients, SI time was not associated with WMLL or VEP P100, while
9HP was associated with WMLL, but not with VEP P100.
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This study shows that RRMS patients early in the disease course
have a longer SI time than healthy controls. SI time was unrelated
to other disease characteristics, WMLL and VEP. We also found that
both hand function (9HP), and SI time were associated with the
test results of the wSDMT, but not with the auditory and oral test
of the same functional domains, PASAT.
In contrast to the study by Fielding et al. (2009b) who found
prolonged saccadic delay in response to composite, but not to
simple cues, we found a prolonged SI time in response to a simple
cue. Our sample size is larger than previous ones, and our patients
had a shorter disease duration and higher EDSS, possibly ac-
counting for the different ﬁndings (Fielding et al., 2009b).
Saccades and cognition are thought to be linked, and recently a
test for eye motor speed was suggested as a bedside assessment
tool in MS (Roberg et al., 2014). These neuropsychological studies
indicate that eye motor disorders may be a sensitive early marker
of disseminated disease. Our study showed increased SI time in
the absence of cognitive difﬁculties. We therefore hypothesize that
SI time and cognitive decline are caused by separate anatomico-
pathological alterations in early RRMS. These domains may notevolve in parallel and identifying the actual impairments may lead
to improved care for the patients.
Slowing of hand function has been recognized as a sign in early
MS (Cutter et al., 1999), and the patients in our study had a slower
hand function than healthy controls in previous studies (Drake
et al., 2010). We did not identify any association between 9HP and
PASAT. In contrast, studies of the components of the MSFC have
identiﬁed associations between 9HP and PASAT in large patient
samples with long disease duration (Cutter et al., 1999; Drake
et al., 2010). The absent association in our study may be explained
either by short disease duration, cognitive intactness or by the
limited patient sample. The signiﬁcant association between 9HP
and the wSDMT test score indicates that hand function is relevant
in solving the wSDMT even in the absence of cognitive
dysfunction.
We found associations between hand motor function and
WMLL, but no association between SI time and WMLL or brain-
stem lesions. However, there is considerable evidence that both
normal appearing white matter (Kutzelnigg et al., 2005; Bodini
et al., 2009) and gray matter (De Stefano et al., 2003; Sailer et al.,
2003; Ceccarelli et al., 2008) may be affected in early RRMS pa-
tients, and associated with speciﬁc symptoms, like cognition and
fatigue (Sepulcre et al., 2009; Nygaard et al., 2014). Cerebellar
pathology is also related to eye movements disorders, as recently
shown in a study of antisaccades and cognition in early MS pa-
tients (Kolbe et al., 2014). Thus our study does not exclude asso-
ciations between SI time and other disease related structural brain
changes.
The oSDMT is the most commonly used test in the neu-
ropsychological assessment of MS patients. From our results,
showing that SI time affects the wSDMT results, we hypothesize
that the results of the oSDMT would be affected by eye motor
G.O. Nygaard et al. / Multiple Sclerosis and Related Disorders 4 (2015) 585–589 589decrements. This has, however, not been directly shown in this
study, and should be tested separately in future studies. Our study
is limited by the fact that the patients were not given both the
written and the oral version of the SDMT. This would have con-
tributed to clarify the different and possibly additional motor skills
required for performance of the wSDMT. Moreover, the controls
did not perform the PASAT, which would have been an additional
strength to our analyses.
Low SDMT score is associated with early cognitive dysfunction
(Deloire et al., 2006), disease development, imaging (Christodou-
lou et al., 2003; Benedict et al., 2004; Filippi et al., 2010) and vo-
cational outcomes (Drake et al., 2010) in MS patients. The SDMT
may be the best available cognitive test for MS patients (Langdon
et al., 2011). The association between wSDMT test score, eye and
hand motor function described in this study may in fact contribute
to the value of the wSDMT in real life. This study therefore does
not oppose the future use of this test, but highlights that impair-
ments other than cognitive difﬁculties may confound the test re-
sults and these should be interpreted with caution in some patient
groups.
In conclusion, slowing of eye movements, as well as hand
motor function, is associated with the wSDMT test score. Clinicians
should be aware that the wSDMT may measure not only cognition,
but also eye movements and hand function in early RRMS patients.Funding
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